Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Waldenström's macroglobulinaemia complicated by pure red cell aplasia: a case report.

× No keyword cloud information.

13 in total

Review 1. Pure red cell aplasia.

Authors: P Fisch; R Handgretinger; H E Schaefer
Journal: Br J Haematol Date: 2000-12 Impact factor: 6.998

Review 2. Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia.

Authors: Meletios Athanasios Dimopoulos; Morie A Gertz; Efstathios Kastritis; Ramon Garcia-Sanz; Eva K Kimby; Veronique Leblond; Jean-Paul Fermand; Giampaolo Merlini; Pierre Morel; Enrica Morra; Enrique M Ocio; Roger Owen; Irene M Ghobrial; John Seymour; Robert A Kyle; Steven P Treon
Journal: J Clin Oncol Date: 2008-12-01 Impact factor: 44.544

3. The International Prognostic Scoring System for Waldenstrom's macroglobulinemia is applicable in patients treated with rituximab-based regimens.

Authors: Meletios Athanasios Dimopoulos; Efstathios Kastritis; Sossana Delimpassi; Athanasios Zomas; Marie Christine Kyrtsonis; Konstantinos Zervas
Journal: Haematologica Date: 2008-07-18 Impact factor: 9.941

4. Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature.

Authors: Kalyani Narra; Hossein Borghaei; Tahseen Al-Saleem; Martin Höglund; Mitchell R Smith
Journal: Leuk Res Date: 2005-07-25 Impact factor: 3.156

5. [Pure red cell aplasia developing during the course of primary macroglobulinemia associated with pseudochylothorax and IgA nephropathy].

Authors: H Uno; N Hino; K Fujiwara; N Sasaki; K Kobayashi
Journal: Rinsho Ketsueki Date: 2001-04

6. Persistent parvovirus B19 infection and pure red cell aplasia in Waldenström's macroglobulinemia: successful treatment with high-dose intravenous immunoglobulin.

Authors: M Karmochkine; E Oksenhendler; M Leruez-Ville; A Jaccard; F Morinet; S Herson
Journal: Am J Hematol Date: 1995-11 Impact factor: 10.047

7. [Primary Waldenström's macroglobulinemia associated with pure red cell aplasia in which Ts/c lymphocytes inhibiting erythroid precursors were detected].

Authors: N Masauzi; J Tanaka; M Watanabe; J Matuura; K Morii; T Naohara; Y Kiyama; T Higa; M Kasai; M Han
Journal: Rinsho Ketsueki Date: 1993-03

Review 8. Waldenström macroglobulinemia: 2012 update on diagnosis, risk stratification, and management.

Authors: Morie A Gertz
Journal: Am J Hematol Date: 2012-05 Impact factor: 10.047

9. Pure red cell aplasia associated with B cell lymphoma: demonstration of bone marrow colony inhibition by serum immunoglobulin.

Authors: R Alter; S S Joshi; J D Verdirame; D D Weisenburger
Journal: Leuk Res Date: 1990 Impact factor: 3.156

10. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group.

Authors: Ken-ichi Sawada; Makoto Hirokawa; Naohito Fujishima; Masanao Teramura; Masami Bessho; Kazuo Dan; Hisashi Tsurumi; Shinji Nakao; Akio Urabe; Mitsuhiro Omine; Keiya Ozawa
Journal: Haematologica Date: 2007-07-20 Impact factor: 9.941

2 in total

1. Treatment of pure red cell aplasia associated with multiple myeloma with biclonal gammopathy using cyclosporine A: a case report.

Authors: Yali Lv; Wenbin Qian
Journal: Int J Clin Exp Med Date: 2015-01-15

2. Clinical Resolution of Red Cell Aplasia Associated del 17p Multiple Myeloma, When Treated With Bortezomib and Dexamethasone.

Authors: Abdullah Ladha; Yelena Fudym; Teresa C Gentile
Journal: J Hematol (Brossard) Date: 2017-01-10

2 in total